Israeli-Dutch Innovation Center

#92 New open EU Covid-19 funding as a means for Dutch-Israeli R&D cooperation

  • Industry Life sciences and health
  • Online since 2020-05-20

The Netherlands-Israel cooperation - here is another cooperation opportunity. The new EU Covid-19 funding! Second Coronavirus (H2020-SC1-PHE-CORONAVIRUS-2020-2) is now on the Funding & Tenders Portal. Submission of proposals is available to applicants.

Check out the 5 topics and links:

- 2A - Re-purposing of manufacturing for vital medical supplies and equipment (https://lnkd.in/dTNxVAT)

- 2B - Medical technologies, Digital tools and Artificial Intelligence (AI) analytics to improve surveillance and care at high Technology Readiness Levels (TRL) (https://lnkd.in/d4cNVxb)

- 2C - Behavioural, social and economic impacts of the outbreak response (https://lnkd.in/danWfW9)

- 2D - Pan-European COVID-19 cohorts (https://lnkd.in/duCXJDE)

- 2E - Networking of existing EU and international cohorts of relevance to COVID-19 (https://lnkd.in/djYYsrH)

Go to website

Maybe you like this as well

  • Chemistry: Dutch Israeli cooperation with Brightlands Chemelot Campus in the Netherlands

    Brightlands Chemelot Campus in the Netherlands is looking for R&D cooperation with Israeli companies and research institutions and also offers a physi...

    Read more
  • Energy: The Netherlands: Executive Programme New Energy Realities - a few places left!

    Read more
  • Health: Israeli Med-tech startup in the field of Obesity and Overweight is looking for Dutch investors

    Melcap system is a dynamic Israeli startup in the medical device and health sector which developed a novel, cost-effective, wireless, ingestible capsu...

    Read more

Get in touch

Do you need some help with extending your network in both The Netherlands or Israel. Connect with us and talk about the possibilities.

  • Israeli-Dutch Innovation Center
    Embassy of the Kingdom of the Netherlands in Israel

  • 14 Abba Hillel Street, Ramat Gan 5250607

  • +972 (0) 52 9530 385

  • [email protected]